Biocon’s research services arm to set up new plant at Mangalore SEZ

01 Apr 2015 Evaluate

Biocon’s research services arm -- Syngene International -- is planning to set up a new plant at Mangalore SEZ to manufacture pharma ingredients and agro chemicals. In this regard, Syngene International is in the process of acquiring around 40 acres of land on leasehold basis in the multi product category.

The land would be used for setting up commercial scale facilities to manufacture novel active pharmaceuticals ingredients, advance ingredients and agro chemical for Syngene’s client.

Biocon is India’s largest and Asia’s leading biotechnology company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

 

Biocon Share Price

392.80 4.55 (1.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×